ADVFN - Advanced Financial Network.
HOME» NYSE » V » VRX Stock Price » VRX Stock News

Valeant Pharma Share News

 Valeant Pharmaceuticals International Stock Price
VRX Stock Price
 Valeant Pharmaceuticals International Stock Chart
VRX Stock Chart
 Valeant Pharmaceuticals International Stock News
VRX Stock News
 Valeant Pharmaceuticals International Company Information
VRX Company Information
 Valeant Pharmaceuticals International Stock Trades
VRX Stock Trades

Sanofi Finalizes Sale Of Dermik To Valeant Pharmaceuticals

PARIS -(Dow Jones)- French drug company Sanofi-Aventis (SAN.FR) announced Monday the finalization of the sale of its Canadian dermatology business, Dermik, to Valeant Pharmaceuticals International Inc. (VRX) for $422.5 million. In a statement, Sanofi said the transaction includes an aesthetic and therapeutic business in the U.S. and Canada, as well as an aesthetic business around the world. Sanofi's Canadian unit will continue its operations in Greater Montreal, said the company. -By Nadya Masidlover, Dow Jones Newswires; +33 1 4017 1740; [email protected]

Stock News for Valeant Pharma (VRX)
DateTimeHeadline
03/24/201703:02:00Valeant Paid CEO $62.7 Million Total -- WSJ
03/23/201718:45:00Valeant CEO Joseph Papa Was Paid $62.7 Million in 2016 -- 4th...
03/23/201714:44:00Valeant CEO Joseph Papa Was Paid $62.7 Million in 2016 -- 3rd...
03/23/201713:51:00Valeant CEO Joseph Papa Was Paid $62.7 Million in 2016 -- 3rd...
03/23/201712:01:00Valeant CEO Joseph Papa Was Paid $62.7 Million in 2016 -- 2nd...
03/23/201711:35:00Valeant CEO Joseph Papa Was Paid $62.7 Million in 2016 -- Update
03/23/201710:11:00Valeant CEO Joseph Papa Was Paid $62.7 Million in 2016
03/23/201708:05:22Proxy Statement (definitive) (def 14a)
03/21/201716:51:10Current Report Filing (8-k)
03/21/201716:30:00Valeant Completes Refinancing Transactions
03/21/201716:30:00Valeant Completes Refinancing Transactions
03/20/201721:45:00Valeant Announces the Early Results of Tender Offers for Its...
03/20/201721:45:00Valeant Announces the Early Results of Tender Offers for Its...
03/20/201717:00:00Bausch + Lomb And Nicox Announce PDUFA Date For Novel Glaucoma...
03/20/201717:00:00Bausch + Lomb And Nicox Announce PDUFA Date For Novel Glaucoma...
03/17/201716:24:22Current Report Filing (8-k)
03/16/201717:13:47Statement of Changes in Beneficial Ownership (4)
03/16/201717:06:04Statement of Changes in Beneficial Ownership (4)
03/16/201716:43:41Statement of Beneficial Ownership (sc 13d)
03/16/201716:32:58Statement of Changes in Beneficial Ownership (4)

Valeant Pharma and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US